Merit Medical Systems, Inc. (MMSI)
Market Cap | 6.16B |
Revenue (ttm) | 1.36B |
Net Income (ttm) | 120.36M |
Shares Out | 58.83M |
EPS (ttm) | 2.03 |
PE Ratio | 51.60 |
Forward PE | 28.72 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 525,973 |
Open | 105.16 |
Previous Close | 104.68 |
Day's Range | 103.95 - 105.78 |
52-Week Range | 70.70 - 111.45 |
Beta | 0.92 |
Analysts | Strong Buy |
Price Target | 110.78 (+5.76%) |
Earnings Date | Apr 29, 2025 |
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bo... [Read more]
Financial Performance
In 2024, Merit Medical Systems's revenue was $1.36 billion, an increase of 7.89% compared to the previous year's $1.26 billion. Earnings were $120.36 million, an increase of 27.48%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for MMSI stock is "Strong Buy." The 12-month stock price forecast is $110.78, which is an increase of 5.76% from the latest price.
News

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
SOUTH JORDAN, Utah, March 25, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that the six-month results from the randomi...

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership
SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred L...

Merit Medical: A Success Story That Keeps Getting Better
Merit Medical continues to outperform, with the share price supported by on-target financial results, incremental M&A, and positive clinical data. The company's Wrapsody stent graft showed almost best...

First Patient Enrolled in Merit Medical's PREEMIE Study
Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants Multicenter, prospective study de...

Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript

Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance
Fourth Quarter Highlights† Reported revenue of $355.2 million, up 9.4% Constant currency revenue* and constant currency revenue, organic* up 10.1% and up 6.1%, respectively GAAP operating margin of 10...

Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025
* Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial measure is included under the heading “Non-GAAP F...

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
SOUTH JORDAN, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that the WRAPSODY...

Merit Medical Announces Resignation of President, Joseph Wright
SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI) (“Merit” or the “Company”), a global leader of healthcare technology, today announced the resignation o...

Fundus Camera Market Global Forecasts and Company Analysis 2025-2033, Profiles of Carl Zeiss Medites, Topcon Medical Systems, Merit Medical Systems, NIDEK, and Revenio Group
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Fundus Camera Market Global Forecast Report by Product Type, End-User, Countries and Company Analysis 2025-2033" report has been added to ResearchAndMark...

Merit Medical's WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm c...

Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical
SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook...

Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd...

Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
SOUTH JORDAN, Utah, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...

Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical
SOUTH JORDAN, Utah, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced it has signed a definitive asset purchase a...

Merit Medical's WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients
In the US pivotal trial, WRAPSODY achieved 89.8% target lesion primary patency at 6 months In the US pivotal trial, WRAPSODY achieved 89.8% target lesion primary patency at 6 months

Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress
SOUTH JORDAN, Utah, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that clinicians ...

Merit Medical Systems, Inc. (MMSI) Q2 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2024 Results Conference Call August 1, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman, and Chief Executive Officer Brian Lloyd...

Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance
Second Quarter 2024 Highlights† Reported revenue of $338.0 million, up 5.6% Constant currency revenue* up 6.6% Constant currency revenue, organic,* up 5.0% GAAP operating margin of 13.6%, compared to ...

Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings
SOUTH JORDAN, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced plans to release findings from its WAVE stud...

Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
SOUTH JORDAN, Utah, July 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has executed an asset purchase agreement ...

Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...

Merit Medical: Undervalued With Multiple Growth Drivers In Play
Merit Medical has shown solid performance with revenue and EBITDA growth, but has only tracked the broader med-tech market higher as investors wait for more exciting drivers. The company's WRAPSODY en...

Merit Medical recalling plastic syringes supplied by Jiangsu Shenli Medical, US FDA says
The U.S. Food and Drug Administration said on Friday that Merit Medical Systems has initiated a recall for plastic syringes supplied by Jiangsu Shenli Medical Production.

Merit Medical Launches basixSKY™ Inflation Device
Versatile analog device offers fast inflation and ease of use, streamlining patient care Versatile analog device offers fast inflation and ease of use, streamlining patient care